Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.
Meda Pharmaceuticals specializes in respiratory, allergy, central nervous system, and cough-cold products.
September 2007:
FDA Approves SOMAŽ (carisoprodol) 250 mg Product in the US »
September 2007:
Meda acquires exclusive rights to potential specialty blockbuster product in the US »
August 2007:
Strategic Acquisition of MedPointe Inc completed »
Meda Pharmaceutical's Philosophy »
Click here to view our Career Opportunities »
